GARY CAIN: Open Payments
NPI 1336267392 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,944 in 104 payments from 21 companies in 2025. Trend: 2023 $2,234 · 2024 $1,976 · 2025 $1,944
Food & beverage: $1,944
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $242 |
| AstraZeneca Pharmaceuticals LP | 7 | $241 |
| Amgen Inc. | 16 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $175 |
| Novo Nordisk Inc | 11 | $153 |
| Lilly USA, LLC | 8 | $141 |
| Lundbeck LLC | 5 | $129 |
| PFIZER INC. | 4 | $95 |
| Abbott Laboratories | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
Products named: Kerendia, REXULTI, JARDIANCE, FARXIGA, VRAYLAR, Wegovy, EVENITY, OTEZLA.
Industry payments across FL — which companies pay providers there.
